Legal Disclaimer
This page provides general legal orientation for Singapore, not legal advice. Regulations change frequently. Always verify current rules with HSA and consult a qualified professional.
Peptide Legal Status in Singapore
Singapore strictly regulates therapeutic products under the Health Products Act. The HSA actively enforces against illegal health products — it seized over 1 million illegal health products in 2025 and removed more than 2,300 online listings. GLP-1 agonists are available by prescription from registered medical practitioners, but unauthorized importation and sale carry severe penalties.
Regulator
HSA (Health Sciences Authority) — Official website
Key Facts
Compounding Pharmacy Rules
Telehealth Prescribing
Peptide Categories in Singapore
Approved
Semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro), liraglutide (Saxenda) — all HSA-registered prescription-only medicines.
Research / Unapproved
BPC-157, TB-500, GHRPs — not HSA-registered. Import, sale, and supply of unregistered therapeutic products is illegal. HSA enforcement is active and penalties are severe.
Banned / Restricted
Unregistered therapeutic products cannot be legally sold or imported. HSA website publishes alerts on illegal health products.
Key Legislation
- Health Products Act (Cap. 122D)
- Medicines Act (Cap. 176)
- Poisons Act (Cap. 234)
Peptides in Singapore: FAQ
Sources
Medical Disclaimer
This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.
Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.
No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.
Peptide Laws in Other Countries
Get international legal updates
Stay informed when country-specific legal pages, routing guidance, and safety guidance change.
No spam. Unsubscribe anytime.